US 11273182
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
granted A61KA61K35/28A61K35/35
Quick answer
US patent 11273182 (Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease) held by Takeda Pharmaceutical Company Limited expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K35/28, A61K35/35, A61P, A61P1/00